International Journal of Gynecological Cancer
Издатель: Elsevier · ISSN 1048-891X · 88 статей
- Pan-Gynecologic Cancer Analysis of ERBB2 Gene Mutations Across More Than 21,000 Tumor Samples
- Optimizing Curative-Intent Treatment for Locally Advanced Cervical Cancer in the KEYNOTE-A18 and INTERLACE Era: Toward Risk-Adapted Care
- Cause-of-Death Spectrum and Competing-Risk Analysis of Index-Cancer-Specific Death in Registry-Defined Dual-Primary Endometrial and Ovarian Cancers: A SEER-Based Population Study
- Beyond Body Mass Index: Visceral Obesity Distance Is Independently Associated With Overall Survival in Endometrial Cancer
- Association of a Homologous Recombination Deficiency Signature with Oncologic Outcomes in Advanced Endometrial Cancer
- Journal Information
- Hormone replacement therapy in gynecologic cancer survivors: bridging the gap between evidence and clinical practice
- Surviving and thriving: evidence-based menopausal care
- European Society for Medical Oncology Gynaecological Cancers Congress 2026: key scientific advances from the oral sessions
- Intra-operative margin assessment in extra-mammary Paget’s disease of the vulva: accuracy and impact on surgical outcomes
- Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial
- Application of small-pelvic adjuvant radiotherapy in early cervical cancer without high-risk factors after hysterectomy
- Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer
- Early post-operative complications after fertility-sparing surgery for cervical carcinoma: a retrospective study of a centralized national cohort of 127 consecutive women
- Integration of immuno-nutritional status into International Federation of Gynecology and Obstetrics risk stratification to predict chemotherapy response and survival in gestational trophoblastic neoplasia
- Actinomycin D versus etoposide, methotrexate, actinomycin D/cyclophosphamide, and vincristine as second-line treatment in low-risk gestational trophoblastic neoplasia with primary methotrexate resistance
- Confluent glands drive the risk of concurrent carcinoma in atypical endometrial hyperplasia: a multi-center external validation study
- Incremental risk of high-grade adverse events with immune checkpoint inhibitors with or without poly(adenosine diphosphate-ribose) polymerase inhibitors in first-line treatment of advanced endometrial cancer: a systematic review and meta-analysis
- Enhanced recovery after surgery in minimally invasive hysterectomy for uterine cancer: identifying predictors of same-day discharge
- Vaginal natural orifice transluminal endoscopic surgery versus conventional laparoscopy for sentinel lymph node mapping in early-stage endometrial cancer: a systematic review and meta-analysis
- Somatic BRCA1 and BRCA2 detection in homologous recombination deficiency testing: concordance of four sequencing workflows with the Myriad myChoice companion diagnostic
- Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications
- Mortality trends and disparities in ovarian cancer among women aged 45 years and older in the United States, 1999-2020: a CDC WONDER analysis
- Treatment and outcome of elderly patients with presumed early ovarian cancer in Germany: real-world observations from the quality-assurance program of the AGO Study Group
- INCIDENCE AND PREDICTIVE FACTORS OF SEVERE LATE COMPLICATIONS AFTER PELVIC EXENTERATION AND/OR INTRAOPERATIVE RADIOTHERAPY FOR GYNECOLOGICAL MALIGNANCIES
- BEYOND PLATINUM: RECONSIDERING THE ROLE OF PLATINUM BASED THERAPY IN THE EVOLVING TREATMENT LANDSCAPE OF OVARIAN CANCER
- Trastuzumab pamirtecan versus chemotherapy in patients with previously treated, human epidermal growth factor receptor 2 (HER2)-expressing, recurrent endometrial cancer: the phase 3 Fern-EC-01 trial (BNT323-01/GOG-3105/ENGOT-EN25)
- Early-onset endometrial cancer beyond obesity and Lynch syndrome
- Defining the tumor immune micro-environment in vulvar squamous cell carcinoma to guide treatment personalization
- Variation in chemotherapy delivery among patients with advanced epithelial ovarian cancer in the Netherlands and its association with survival: a nationwide cohort study